Profession
Maine data restriction law blocked
NEWS IN BRIEF — Posted Jan. 21, 2008
A federal judge in Maine ruled in December 2007 that a state law allowing physicians to restrict drugmakers' access to their prescribing data is unconstitutional. The law, which had been set to take effect Jan. 1, would have enabled doctors to opt out of having their prescription information sold to data-mining firms such as IMS Health -- the lead plaintiff in the lawsuit -- that in turn package the information for drug reps to use when detailing physicians.
U.S. District Judge John Woodcock's ruling largely agreed with an April 2007 ruling by a federal judge in New Hampshire who overturned that state's total ban on the sale of prescribing data. The Maine law, Woodcock said in his opinion, would "violate the free speech guarantee of the First Amendment" and prohibit "the transfer of truthful commercial information."
IMS Health and other data-mining firms also have challenged in federal court a Vermont law that is similar to Maine's.
The Maine attorney general's office expressed disappointment with the ruling. A decision on whether to appeal had not been made by press time, though the legislator who sponsored the law said she expects one. The U.S. 1st Circuit Court of Appeals could decide to hear the Maine and New Hampshire cases jointly.
The American Medical Association opposes state laws restricting the sale of prescribing data because they could impede commercial research efforts. In 2006, the AMA introduced the Physician Data Restriction Program. Doctors can enroll in the program to limit drug reps' access to their data by visiting the AMA's PDRP Web site (link).
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/01/21/prbf0121.htm.












